In vitro evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2 (2021)
Attributed to:
A One Health approach to pan-valent morbillivirus vaccines
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.02.01.429199
Publication URI: http://dx.doi.org/10.1101/2021.02.01.429199
Type: Preprint